Fatty acid amide hydrolase inhibitors display broad selectivity and inhibit multiple carboxylesterases as off-targets
- 9 January 2007
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 52 (4) , 1095-1105
- https://doi.org/10.1016/j.neuropharm.2006.11.009
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- The Putative Endocannabinoid Transport Blocker LY2183240 Is a Potent Inhibitor of FAAH and Several Other Brain Serine HydrolasesJournal of the American Chemical Society, 2006
- The fatty-acid amide hydrolase inhibitor URB597 does not affect triacylglycerol hydrolysis in rat tissuesPharmacological Research, 2006
- Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanismsBritish Journal of Pharmacology, 2006
- Mechanism of Carbamate Inactivation of FAAH: Implications for the Design of Covalent Inhibitors and In Vivo Functional Probes for EnzymesChemistry & Biology, 2005
- Discovery of a Potent, Selective, and Efficacious Class of Reversible α-Ketoheterocycle Inhibitors of Fatty Acid Amide Hydrolase Effective as AnalgesicsJournal of Medicinal Chemistry, 2004
- Endocannabinoids Acting at Cannabinoid-1 Receptors Regulate Cardiovascular Function in HypertensionCirculation, 2004
- Structural Adaptations in a Membrane Enzyme That Terminates Endocannabinoid SignalingScience, 2002
- Exceptionally potent inhibitors of fatty acid amide hydrolase: The enzyme responsible for degradation of endogenous oleamide and anandamideProceedings of the National Academy of Sciences, 2000
- Potentiation of anandamide hypotension by the transport inhibitor, AM404European Journal of Pharmacology, 1997
- Functional Role of High-Affinity Anandamide Transport, as Revealed by Selective InhibitionScience, 1997